Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 49

1.

Urinary free light chains may help to identify infection in patients with elevated systemic inflammation due to rheumatic disease.

Bramlage CP, Froelich B, Wallbach M, Minguet J, Grupp C, Deutsch C, Bramlage P, Müller GA, Koziolek M.

Rheumatol Int. 2017 Apr;37(4):599-605. doi: 10.1007/s00296-017-3666-9. Epub 2017 Feb 18.

PMID:
28214923
2.

The significance and predictive value of free light chains in the urine of patients with chronic inflammatory rheumatic disease.

Bramlage CP, Froelich B, Wallbach M, Minguet J, Grupp C, Deutsch C, Bramlage P, Koziolek M, Müller GA.

Clin Rheumatol. 2016 Dec;35(12):2939-2946. Epub 2016 Oct 12.

PMID:
27734231
3.

Drug-induced dilemma: angiokeratomas and decreased renal function.

Schliep S, Kiesewetter F, Simon M, Grupp C, Heinzerling L.

Am J Med. 2014 Jul;127(7):598-600. doi: 10.1016/j.amjmed.2014.03.034. Epub 2014 Apr 13. No abstract available.

PMID:
24736246
4.

Impaired immune defense in hemodialysis patients: role of α-defensins?

Grupp C, Troche-Polzien I, Noeding C, Mueller CA, Mueller GA.

Hemodial Int. 2014 Apr;18(2):443-9. doi: 10.1111/hdi.12121. Epub 2013 Dec 17.

PMID:
24341412
5.

The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial.

Baigent C, Landray MJ, Reith C, Emberson J, Wheeler DC, Tomson C, Wanner C, Krane V, Cass A, Craig J, Neal B, Jiang L, Hooi LS, Levin A, Agodoa L, Gaziano M, Kasiske B, Walker R, Massy ZA, Feldt-Rasmussen B, Krairittichai U, Ophascharoensuk V, Fellström B, Holdaas H, Tesar V, Wiecek A, Grobbee D, de Zeeuw D, Grönhagen-Riska C, Dasgupta T, Lewis D, Herrington W, Mafham M, Majoni W, Wallendszus K, Grimm R, Pedersen T, Tobert J, Armitage J, Baxter A, Bray C, Chen Y, Chen Z, Hill M, Knott C, Parish S, Simpson D, Sleight P, Young A, Collins R; SHARP Investigators..

Lancet. 2011 Jun 25;377(9784):2181-92. doi: 10.1016/S0140-6736(11)60739-3. Epub 2011 Jun 12.

6.

AT1 receptor antagonist candesartan attenuates genomic damage in peripheral blood lymphocytes of patients on maintenance hemodialysis treatment.

Schupp N, Rutkowski P, Sebeková K, Klassen A, Bahner U, Grupp C, Heidland A, Stopper H.

Kidney Blood Press Res. 2011;34(3):167-72. doi: 10.1159/000326805. Epub 2011 Apr 7.

7.

Retrospective analysis of long-term lipid apheresis at a single center.

Koziolek MJ, Hennig U, Zapf A, Bramlage C, Grupp C, Armstrong VW, Strutz F, Müller GA.

Ther Apher Dial. 2010 Apr;14(2):143-52. doi: 10.1111/j.1744-9987.2009.00747.x.

PMID:
20438535
8.

Antibodies to platelet factor 4-heparin complex and outcome in hemodialysis patients with diabetes.

Krane V, Berger M, Lilienthal J, Winkler K, Schambeck C, Wanner C; German Diabetes and Dialysis Study Investigators..

Clin J Am Soc Nephrol. 2010 May;5(5):874-81. doi: 10.2215/CJN.01170209. Epub 2010 Feb 25.

9.

[Microalbuminuria and albuminuria: differential diagnosis and consequences for treatment].

Koziolek MJ, Bramlage CP, Vasko R, Grupp C, Müller GA.

Dtsch Med Wochenschr. 2009 Aug;134(34-35):1681-5. doi: 10.1055/s-0029-1234000. Epub 2009 Aug 25. Review. German.

PMID:
19707964
10.

Multiple ITAM-coupled NK-cell receptors engage the Bcl10/Malt1 complex via Carma1 for NF-kappaB and MAPK activation to selectively control cytokine production.

Gross O, Grupp C, Steinberg C, Zimmermann S, Strasser D, Hannesschläger N, Reindl W, Jonsson H, Huo H, Littman DR, Peschel C, Yokoyama WM, Krug A, Ruland J.

Blood. 2008 Sep 15;112(6):2421-8. doi: 10.1182/blood-2007-11-123513. Epub 2008 Jan 11.

11.

Osmoregulation of aldose reductase and sorbitol dehydrogenase in cultivated interstitial cells of rat renal inner medulla.

Steffgen J, Kampfer K, Grupp C, Langenberg C, Müller GA, Grunewald RW.

Nephrol Dial Transplant. 2003 Nov;18(11):2255-61.

PMID:
14551351
12.

Lectin staining for urine cytologic monitoring after kidney transplantation.

Grupp C, Hemprich U, John H, Braun F, Lorf T, Armstrong VW, Ringe B, Müller GA.

Transplant Proc. 2002 Aug;34(5):1751-2. No abstract available.

PMID:
12176562
13.

Lectin staining for urine cytologic monitoring after kidney transplantation.

Grupp C, Hemprich U, John H, Braun F, Lorf T, Armstrong VW, Sattler B, Ringe B, Müller GA.

Nephrol Dial Transplant. 2002 Aug;17(8):1491-6.

PMID:
12147800
14.

Sorbitol transport in rat renal inner medullary interstitial cells.

Schüttert JB, Fiedler GM, Grupp C, Blaschke S, Grunewald RW.

Kidney Int. 2002 Apr;61(4):1407-15.

15.

A case of late-onset primary hyperoxaluria type 1.

Blaschke S, Grupp C, Haase J, Kleinoeder T, Hallermann C, Troche I, Gröne HJ, Müller GA.

Am J Kidney Dis. 2002 Feb;39(2):E11.

PMID:
11840402
16.

Cellular distribution and function of soluble guanylyl cyclase in rat kidney and liver.

Theilig F, Bostanjoglo M, Pavenstädt H, Grupp C, Holland G, Slosarek I, Gressner AM, Russwurm M, Koesling D, Bachmann S.

J Am Soc Nephrol. 2001 Nov;12(11):2209-20.

17.

Pharmacokinetics of tacrolimus primary immunosuppression in kidney transplant recipients.

Braun F, Schütz E, Peters B, Talaulicar R, Grupp C, Undre N, Schäfer A, Armstrong VW, Oellerich M, Ringe B.

Transplant Proc. 2001 May;33(3):2127-8. No abstract available.

PMID:
11377473
19.

A novel model to study renal myofibroblast formation in vitro.

Grupp C, Troche I, Klass C, Köhler M, Müller GA.

Kidney Int. 2001 Feb;59(2):543-53.

20.

Identification of nucleated cells in urine using lectin staining.

Grupp C, John H, Hemprich U, Singer A, Munzel U, Müller GA.

Am J Kidney Dis. 2001 Jan;37(1):84-93.

PMID:
11136172

Supplemental Content

Loading ...
Support Center